#BioTechStartup

SynDevRx Chief Business Officer Jim Shanahan lists the rationale behind selecting evexomostat as the company’s lead candidate.
#SyntheticBiology #DrugDiscovery #LifeSciences #BiotechInnovation #BiotechInvestor #HealthcareInvesting #VentureCapital #BioTechStartup #HealthTech #MedTech #BioPharma

Cellarim Labs secured ₹6 crore in seed funding, co-led by 3i Partners and Venture Catalysts, to advance its cell-free biomanufacturing for beauty ingredients.


#CellarimLabs #BiotechStartup #BioManufacturing #SeedFunding #deccanfounders

Fundraising 🇬🇧 Epoch Biodesign Secures Significant Series A Funding Epoch Biodesign, a London biotech startup, secured $18.3 million in Series A funding to enhance enzymatic recycling technology for cost-effective plastics.

Epoch Biodesign: Innovating enzymatic recycling 🌿

$18.3M Series A funding to revolutionize plastic recycling

#EpochBiodesign #BiotechStartup #EnzymaticRecycling #GreenInnovation

ep.10/46 🇺🇸 🇮🇳 Startups Accepted by Y Combinator 2024 Three founders, Prof. Michael Dustin, Dr. Ashwin Jainarayanan, and Dr. Ashwin Nandakumar, successfully raised funds led by Felicis and Refactor. The round also included participation from Y Combinator and various notable ventures and angel investors, highlighting significant investor interest in their initiative.

Innovative cancer & genetic medicine delivery 🧬

🇺🇸 🇮🇳 Biotech startup raises $7.14M in seed funding

#BiotechStartup #CancerTreatments #GeneticMedicine #BiotechInvestments #StartupFounders #SeedFunding #TherapeuticDelivery

Gene Control Startup Concinnity Secures £3M Seed Funding to Advance Gene Therapy Safety - SynBioBeta

Using a combination of AI and synthetic biology, Concinnity Genetics is developing RNA-based systems that enable precise post-dosing control of gene therapies

#Concinnity #GeneTherapy #SeedFunding #BiotechStartup #GeneControl #HealthTech